RSS Parrot

BETA

🦜 (multiple sclerosis[TIAB] AND microglia [TIAB] AND (modulate [tiab] OR therapy [tiab]) )

@pubmed.ncbi.nlm.nih.gov.rss-feed.feed.id.1fu8xzk4yhhewwxhjpj0wias65oqqskkl3us0d7kijxyjifeei.utm.content.1fu8xzk4yhhewwxhjpj0wias65oqqskkl3us0d7kijxyjifeei.utm.source.rss-parrot-bot.ff.20260423183435.utm.medium.rss.v.2.19.0.post6.133c1fe@rss-parrot.net

I'm an automated parrot! I relay a website's RSS feed to the Fediverse. Every time a new post appears in the feed, I toot about it. Follow me to get all new posts in your Mastodon timeline! Brought to you by the RSS Parrot.

---

(multiple sclerosis[TIAB] AND microglia [TIAB] AND (modulate [tiab] OR therapy [tiab]) ): Latest results from PubMed

Your feed and you don't want it here? Just e-mail the birb.

Site URL: pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&utm_content=1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi&utm_source=RSS-Parrot-Bot&ff=20260423183435&utm_medium=rss&v=2.19.0.post6+133c1fe

Feed URL: pubmed.ncbi.nlm.nih.gov/rss/search/1fU8XZK4YhHEwwxHJPj0wias65oQqskKl3Us0d7KijXyJIFEEi/

Posts: 10

Followers: 1

Microglia in Alzheimer's disease: from pathogenic mechanisms to therapeutic targeting

Published: November 10, 2026 11:00

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder driven by β-amyloid (Aβ) deposition, tau hyperphosphorylation, synaptic dysfunction, neuroinflammation, vascular injury, and metabolic dysregulation. Recent advances in single-cell,…

Neuroinflammation in Alzheimer's disease: pathogenic signaling, biomarkers, and emerging therapeutic interventions

Published: November 7, 2026 11:00

Alzheimer's disease (AD) is the leading cause of dementia worldwide, characterized by progressive cognitive decline and neurodegeneration. Although amyloid-β plaques and hyperphosphorylated tau are major pathological hallmarks, increasing evidence…

Noncanonical Signaling Network of Nogo-A: A New Perspective on Multi-target Regulation, Neuroplasticity, and Disease Intervention Beyond NgR

Published: November 4, 2026 11:00

The membrane protein Nogo-A, initially identified for its inhibitory role in axonal regeneration through the Nogo receptor (NgR), is now recognized as a central hub in a complex noncanonical signaling network. Recent evidence indicates that Nogo-A engages…

Photobiomodulation as a regulator of neuroinflammation: mechanistic insights and therapeutic potential in brain disorders

Published: October 31, 2026 10:00

Brain disorders, including neurodegenerative, neuropsychiatric, and cerebrovascular diseases, represent a growing global health challenge contributing to disability and mortality worldwide. Although these conditions differ in etiology and clinical…

Combining pharmacological and non-invasive brain stimulation strategies to promote remyelination in multiple sclerosis

Published: October 29, 2026 10:00

Remyelination in multiple sclerosis (MS) fails for several, partly overlapping reasons. The differentiation of oligodendrocyte precursor cells into myelin-producing oligodendrocytes is impaired both by intrinsic factors and by the surrounding lesion…

Exploring Progressive Multiple Sclerosis and the Therapeutic Potential of BTK Inhibitors Based on EBV-driven B Cell-microglia Interactions

Published: October 12, 2026 10:00

Progressive Multiple Sclerosis (PMS) remains a major cause of irreversible disability in Multiple Sclerosis (MS), yet current disease-modifying therapies incompletely address the compartmentalized Central Nervous System (CNS) inflammation, sustained…

The ACOD1-itaconate axis in anti-neuroinflammation and protection against neurodegenerative diseases

Published: October 9, 2026 10:00

Chronic neuroinflammation mediated by activated microglia constitutes a central pathogenic mechanism underlying neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS). Despite substantial…

The Role of Mast Cells and Their Potential as a Therapeutic Target For Neuroinflammation

Published: October 6, 2026 10:00

Neuroinflammation is increasingly recognized as a central mechanism underlying the onset and progression of numerous neurological disorders, including neurodegenerative, autoimmune, and cerebrovascular diseases. Although microglia and astrocytes are…

Impact of Oral Cladribine on TSPO-PET-Measurable Immune Cell Activation in Multiple Sclerosis

Published: September 30, 2026 10:00

CONCLUSION: TSPO-binding in the NAWM increased during oral cladribine treatment despite suppressed relapses and decreased sNfL Z-score. These exploratory findings raise the possibility that cladribine may have limited ability to control smoldering…

Shedding Light on Interaction Between Neurological Symptoms and Psychiatric Episodes in Multiple Sclerosis: Novel Hypothesis and Therapeutic Avenues

Published: September 19, 2026 10:00

Multiple sclerosis is a chronic neuroinflammatory disorder, with different central nervous system lesions being induced at distinct time points. Anxiety disorders and major depressive disorder are common comorbidities of multiple sclerosis. In such cases,…